Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s):  LBLTF

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.


TSXV:LBL.H - Post by User

Post by PingPong888on Apr 20, 2020 12:22am
296 Views
Post# 30928492

Read in between the lines!

Read in between the lines! A lot of folks have b een messaging me - asking me whats-up with Lattice Biologics. 

I want my friends to read the following statement - https://www.montanarightnow.com/all_abc_fox/butte-respiratory-specialist-working-on-coronavirus-stem-cell-trial/article_a1a9f18a-7f4f-11ea-8dda-e702386a988b.html

Quote from the news release: 

Once phase one of the trial begins, they hope to have results in about two weeks. The Montana study is one of three being conducted worldwide by the company
 
"Well I think it is very important, time is of the essence in order to get good results quickly and know if this is a possible scenario that we can treat it," said Green
 

Note: 

There reason why this isn't in the IRROC news release is because majority of this is masked with old news with little timbits of significant news. 

The new news release will be of quality and significance. This is practically the only stem cell stock trading on the TSX market. 

Boys I have a good feeling about this. 
 

<< Previous
Bullboard Posts
Next >>